Are You Living With

Lichen Planopilaris?

You May Qualify for the ALPINE Clinical Study.

Researchers are exploring a possible treatment option in adults diagnosed with lichen planopilaris.

You may qualify to take part in this study if you are living with the inflammatory effects of lichen planopilaris and are at least 18 years old.

Watch our video to learn more about the ALPINE clinical study for people living with lichen planopilaris.

About the ALPINE Study

Researchers are testing a possible treatment option, called brepocitinib, in adults diagnosed with lichen planopilaris. They are evaluating the treatment’s safety, its effects on symptoms, and how the body responds over time.

What should I expect?

1. Screening

(Up to 1 Month)

1. Screening

(Up to 1 Month)

First, you will have a screening visit to see whether you qualify. If you qualify and choose to participate, you will be in the study for a little over 1 year.

2. First Study Treatment Phase

(About 16 Weeks)

2. First Study Treatment Phase

(About 16 Weeks)

During the first phase, you will receive either the treatment option or a placebo (a look-alike tablet that does not contain active ingredients). This phase lasts about 6 months.

3. Second Study Treatment Phase

(About 32 Weeks)

3. Second Study Treatment Phase

(About 32 Weeks)

During the second phase, all participants will receive the treatment. This phase lasts about 7 months.

4. Follow-Up

(4 Weeks)

4. Follow-Up

(4 Weeks)

About 1 month after taking your last dose of the treatment, you will have a final series of medical tests.

Throughout the study, you will have regular health assessments and check-ins with the research team.

You will receive the investigational medicine or placebo and all study-related care at no cost. Participants who follow study requirements and complete study visits may be compensated and may also be reimbursed for study-related expenses, such as transportation, parking, and meals.

What is the investigational medicine?

The treatment is a tablet that is taken once a day. It is designed to decrease inflammation, which may help reduce the symptoms of lichen planopilaris. It has not yet been approved by any regulatory agency.

Do I Qualify?

Answer a few short questions to find out if you may qualify to take part in the ALPINE study.

Are you at least 18 years old?
Have you been diagnosed with lichen planopilaris?
Do you have symptoms affecting your scalp?

If you answered yes to these questions, you may qualify for this study. Please click the button below to complete the contact form and a study representative will be in touch.

Contact Me

Find a Study Site

Below is a list of locations for the ALPINE Study.

Home About the ALPINE Study Do I Qualify?Site Resources